Literature DB >> 33063148

The incidence of NOS3 gene polymorphisms on newborns with large and small birth weight.

Thaysa Walléria de Aragão Santos1, Andriu Dos Santos Catena2, Sandra da Silva Mattos3, José Luiz de Lima Filho2, Danyelly Bruneska Gondim Martins2,4.   

Abstract

The NOS3 gene polymorphisms T-786C, G894T and VNTR 4b/a are associated with a predisposition to the development of Metabolic Syndrome (MetS). The NOS3 gene contributes to a normal pregnancy and fetal development. According to their birthweight, newborns can be classified as: small (SGA), adequate (AGA) or large (LGA) for gestational age. The SGA and LGA present a higher risk of developing disorders related to MetS, both during childhood and adulthood. Therefore, the aim of this work is to relate the incidence of G894T, T-786C and VNTR 4b/a on SGA and LGA newborns and their mothers. 204 blood samples were collected from mothers (102) and the umbilical cords of 102 newborns (SGA = 12; AGA = 47; LGA = 43). The genotyping was performed through PCR-RFLP to evaluate presence of the G894T, T-786C and VNTR 4b/a polymorphisms. A significant difference was found between the groups of newborns in the genotypic frequency of T-786C, but without Hardy-Weinberg equilibrium. The VNTR 4b/a and the G894T polymorphisms showed no significance between the groups. The haplotype analysis showed that the SGA newborns presented the higher frequency of 4aGT (9.8%) and of the 4aTT combination (25.4%), while LGA newborns presented the higher frequency of the 4bTT haplotype (23%). Only the SGA newborns and their mothers presented the 4aTC haplotype. In conclusion, the NOS3 polymorphisms do not appear to be a factor to inadequate birth weight. However, the G894T and VNTR 4b/a polymorphisms, and the haplotype 4aTC, seem to influence the occurrence of SGA.

Entities:  

Keywords:  Metabolic syndrome; NOS3 polymorphism; Newborn

Mesh:

Substances:

Year:  2020        PMID: 33063148     DOI: 10.1007/s11033-020-05897-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  32 in total

1.  The association of endothelial nitric oxide synthase G894T polymorphism with C-reactive protein level and metabolic syndrome in a Chinese study group.

Authors:  Ming-Chia Hsieh; Jeng-Yueh Hsiao; Kai-Jen Tien; Shun-Jen Chang; Pi-Chen Lin; Shih-Chieh Hsu; Hui-Ting Liang; Hung-Chun Chen; Shiu-Ru Lin
Journal:  Metabolism       Date:  2008-08       Impact factor: 8.694

2.  Association of endothelial nitric oxide synthase gene variants (-786 T>C, intron 4 b/a VNTR and 894 G>T) with idiopathic recurrent pregnancy loss: A case-control study with haplotype and in silico analysis.

Authors:  Alireza Azani; Asghar Hosseinzadeh; Roya Azadkhah; Ali Akbar Poursadegh Zonouzi; Ahmad Poursadegh Zonouzi; Younes Aftabi; Hourieh Khani; Leida Heidary; Shahla Danaii; Nasrin Bargahi; Nasser Pouladi; Sayed Mostafa Hosseini
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2017-05-30       Impact factor: 2.435

Review 3.  Nitric oxide synthases: regulation and function.

Authors:  Ulrich Förstermann; William C Sessa
Journal:  Eur Heart J       Date:  2011-09-01       Impact factor: 29.983

4.  Genetic variants of the endothelial NO synthase gene (eNOS) may confer increased risk of sporadic congenital heart disease.

Authors:  K Zhou; Y Wang; W Peng; J Sun; Y M Qing; X M Mo
Journal:  Genet Mol Res       Date:  2014-05-16

Review 5.  Regulation of myometrial circulation and uterine vascular tone by constitutive nitric oxide.

Authors:  Noboru Toda; Hiroshi Toda; Tomio Okamura
Journal:  Eur J Pharmacol       Date:  2013-07-16       Impact factor: 4.432

6.  Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.

Authors:  Sandhya Mehta; Sabyasachi Ghosh; Stephen Sander; Effie Kuti; William K Mountford
Journal:  J Manag Care Spec Pharm       Date:  2018-03

7.  Association between endothelial nitric oxide synthase polymorphisms and risk of metabolic syndrome.

Authors:  Chiu-Shong Liu; Ru-Jiun Huang; Fung-Chang Sung; Cheng-Chieh Lin; Chih-Ching Yeh
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

8.  Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco.

Authors:  Hind Hassani Idrissi; Wiam Hmimech; Brehima Diakite; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Meta Gene       Date:  2016-04-03

9.  Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS).

Authors:  Isabel Aguilar-Palacio; Sara Malo; Cristina Feja; MªJesús Lallana; Montserrat León-Latre; José Antonio Casasnovas; MªJosé Rabanaque; Eliseo Guallar
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

10.  An association between the endothelial nitric oxide synthase gene G894T polymorphism and premature coronary artery disease: a meta-analysis.

Authors:  Boqian Zhu; Xinmin Si; Yaoyao Gong; Chengchun Tang; Gaoliang Yan; Dong Wang; Yong Qiao; Bo Liu; Jiantong Hou
Journal:  Oncotarget       Date:  2017-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.